MSA Safety Inc MSA

Healthcare SIC 3842 - Orthopedic, Prosthetic & Surgical Appliances & Supplies NAICS Manufacturing › Miscellaneous Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical Appliance and Supplies Manufacturing derived NYSE

Last close 182.26 2026-10-23
Market cap $7.03B 2026-06-30 share count
52-week range 151.10 - 208.92

Valuation FY2025 figures against the last close

P/S3.8x
P/E25.7x
P/FCF23.8x
EV/EBITDA16.8x
Dividend yield1.2%
Diluted EPS7.09

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • Other
Revenue by geography, 2 categories over 3 years. The same figures are in the table below. FY2025 United States, FY2025: 943.4M (50.3%) 50% United States Other, FY2025: 931.5M (49.7%) 50% Other FY2024 United States, FY2024: 955M (52.8%) 53% Other, FY2024: 853.2M (47.2%) 47% FY2023 United States, FY2023: 961.1M (53.8%) 54% Other, FY2023: 826.6M (46.2%) 46%
Region FY2025FY2024FY2023
United States $943.4M $955.0M $961.1M
Other $931.5M $853.2M $826.6M

As the company reported it, from the “Segment Information - Geographic Information on Sales to External Customers (Detail)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.87B$1.81B$1.79B$1.53B$1.40B$1.35B$1.40B$1.36B$1.20B$1.15B
Cost of revenue $1.00B$947.7M$935.5M$854.1M$784.8M$752.7M$763.4M$746.2M$657.9M$627.3M
Gross profit $871.1M$860.4M$852.1M$673.8M$615.3M$595.5M$638.6M$611.9M$538.9M$522.2M
R&D $65.3M$66.5M$68.0M$57.0M$57.8M$58.3M$57.8M$52.7M$50.1M$46.8M
SG&A $414.3M$394.7M$396.6M$338.9M$332.9M$290.3M$330.5M$324.8M$300.1M$308.2M
Operating income $371.8M$389.2M$231.3M$239.1M$22.8M$171.9M$188.2M$173.5M$39.6M$160.7M
Interest expense $31.8M$36.9M$46.7M$21.7M$10.8M$9.4M$13.6M$18.9M$15.4M$16.4M
Pre-tax income $366.4M$375.0M$206.7M$238.5M$23.6M$168.1M$185.8M$162.3M$29.8M$151.9M
Income tax $87.5M$90.0M$148.1M$58.9M$1.8M$43.0M$46.5M$37.2M$2.8M$57.8M
Net income $278.9M$285.0M$58.6M$179.6M$21.3M$124.1M$138.0M$124.2M$26.0M$91.9M
EPS, basic 7.117.241.494.580.543.193.563.230.682.45
EPS, diluted 7.097.211.484.560.543.153.523.180.672.42
Shares, diluted (wtd. avg.) 39.3M39.5M39.5M39.4M39.4M39.3M39.2M39.0M38.7M38.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $165.1M$164.6M$146.4M$164.4M$141.4M$161.0M$152.5M$140.6M$137.9M$115.0M
Receivables $306.5M$279.2M$294.7M$297.0M$254.2M$252.3M$255.1M$245.0M$244.2M$209.5M
Inventory $343.0M$296.8M$292.6M$338.3M$280.6M$245.0M$185.0M$156.6M$153.7M$103.1M
Total current assets $869.3M$803.0M$786.3M$880.1M$792.8M$801.4M$693.4M$656.6M$622.3M$472.8M
Property, plant and equipment $283.1M$211.9M$211.9M$207.6M$207.8M$189.6M$167.0M$157.9M$157.0M$148.7M
Goodwill $731.6M$620.9M$627.5M$620.6M$636.9M$443.3M$436.7M$413.6M$422.2M$333.3M
Other intangibles $299.1M$246.4M$266.1M$281.9M$306.9M$161.1M$171.3M$169.5M$183.1M$77.0M
Total assets $2.55B$2.21B$2.17B$2.38B$2.40B$1.92B$1.78B$1.61B$1.68B$1.35B
Accounts payable $110.8M$108.2M$111.9M$112.5M$106.8M$86.9M$89.1M$78.4M$87.1M$62.7M
Short-term debt $8.2M$26.4M$26.5M$7.4M$0$20.0M$20.0M$20.0M$26.7M$26.7M
Total current liabilities $289.2M$288.1M$332.8M$345.9M$330.6M$310.5M$277.5M$282.1M$289.3M$221.4M
Long-term debt $572.7M$481.6M$575.2M$565.4M$597.7M$287.2M$328.4M$341.3M$447.8M$363.8M
Total liabilities $1.19B$1.06B$1.20B$1.45B$1.56B$1.07B$1.01B$968.5M$1.08B$792.7M
Retained earnings $1.55B$1.35B$1.14B$1.16B$1.05B$1.10B$1.01B$935.6M$868.7M$901.4M
Total equity $1.37B$1.14B$966.8M$923.7M$834.4M$839.2M$725.8M$633.9M$597.6M$558.2M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $363.9M$296.4M$92.9M$157.5M$199.1M$206.6M$165.0M$263.9M$230.3M$134.9M
Depreciation and amortisation $71.6M$64.3M$60.8M$56.3M$45.4M$39.7M$38.0M$37.9M$37.9M$35.3M
Stock-based compensation $15.2M$18.2M$30.0M$19.6M$18.9M$6.9M$13.8M$12.2M$11.8M$9.2M
Capital expenditure $68.4M$54.2M$42.8M$42.6M$43.8M$48.9M$36.6M$34.0M$23.7M$25.5M
Investing cash flow -$257.6M-$53.8M-$40.0M-$4.5M-$415.5M-$72.8M-$64.2M-$84.4M-$239.2M-$25.5M
Financing cash flow -$105.5M-$208.7M-$52.3M-$113.3M$203.9M-$126.5M-$84.6M-$163.3M$25.6M-$99.3M
Dividends paid $82.3M$78.8M$73.5M$71.5M$68.6M$66.6M$63.5M$57.2M$52.5M$49.1M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000066570-26-000005.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 500M 1B 1.5B 2B Revenue, FY2016: 1.1B Gross profit, FY2016: 522.2M Net income, FY2016: 91.9M Revenue, FY2017: 1.2B Gross profit, FY2017: 538.9M Net income, FY2017: 26M Revenue, FY2018: 1.4B Gross profit, FY2018: 611.9M Net income, FY2018: 124.2M Revenue, FY2019: 1.4B Gross profit, FY2019: 638.6M Net income, FY2019: 138M Revenue, FY2020: 1.3B Gross profit, FY2020: 595.5M Net income, FY2020: 124.1M Revenue, FY2021: 1.4B Gross profit, FY2021: 615.3M Net income, FY2021: 21.3M Revenue, FY2022: 1.5B Gross profit, FY2022: 673.8M Net income, FY2022: 179.6M Revenue, FY2023: 1.8B Gross profit, FY2023: 852.1M Net income, FY2023: 58.6M Revenue, FY2024: 1.8B Gross profit, FY2024: 860.4M Net income, FY2024: 285M Revenue, FY2025: 1.9B Gross profit, FY2025: 871.1M Net income, FY2025: 278.9M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $1.15B $1.20B $1.36B $1.40B $1.35B $1.40B $1.53B $1.79B $1.81B $1.87B
Gross profit $522.2M $538.9M $611.9M $638.6M $595.5M $615.3M $673.8M $852.1M $860.4M $871.1M
Net income $91.9M $26.0M $124.2M $138.0M $124.1M $21.3M $179.6M $58.6M $285.0M $278.9M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced Item 2.02
  • Other event Item 8.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3842

TickerCompanyMarket capP/ERevenue growth
ISRG INTUITIVE SURGICAL INC $159.78B 57.5x 20.5%
EW Edwards Lifesciences Corp $51.34B 48.7x 11.5%
STE STERIS plc $22.63B 29.3x 8.7%
ZBH ZIMMER BIOMET HOLDINGS, INC. $18.80B 27.8x 7.2%
ALGN ALIGN TECHNOLOGY INC $10.98B 27.3x 0.9%
ESTA ESTABLISHMENT LABS HOLDINGS INC. $1.90B — 27.1%
CDRE Cadre Holdings, Inc. $1.28B 29.4x 7.5%
ENOV Enovis CORP $1.22B — 6.7%